68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients

NCT04796467 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 68Ga-PSMA-617
DRUG: 68Ga-P16-093

Sponsor

Peking Union Medical College Hospital